Anti-KIR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-KIR, covering 2015-05-15 to 2015-05-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma [Phase 2]